Tysabri 300 mg, Konzentrat zur Herstellung einer Infusionslösung
7680572730012
CH-57273
Konzentrat
Associated product:
TYSABRI conc perf 300 mg/15ml fl 15 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
52.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1671.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2007
Authorization holder
Biogen Switzerland AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 57273
- Drug name
- Tysabri 300 mg, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AG03
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 03/05/2007
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- TYSABRI conc perf 300 mg/15ml fl 15 ml
- Description (DE)
- TYSABRI Inf Konz 300 mg/15ml Fl 15 ml
- Market launch
- 03/05/2007
- Narcotic (BTM)
- No